The AARC government affairs agenda is prioritized with the goal of advancing the profession and enhancing pulmonary patient access to care and education.  The AARC is guided by our strategic plan which has input from the Board of Directors and other voluntary leaders.  The AARC collaborates with the pulmonary community, patient advocacy groups, and other organizations through coalitions and partnerships on a variety of topics.  As advocates for our members, AARC supports initiatives that help individuals with chronic respiratory disease, promote the respiratory care profession, and highlight the value of respiratory therapists as essential health care professionals. 

AARC interacts with Congressional leaders, the Centers for Medicare & Medicaid Services (CMS), and the Food and Drug Administration (FDA) on a regular basis. The AARC is also a member of several important advocacy coalitions such as the ATS Oxygen Workgroup, ATS Pulmonary Workgroup, Telehealth/Remote Patient Monitoring Coalition, Allied Health Professionals Coalition, Tobacco Control Partners Coalition, and the National, Heart, Lung, and Blood Institute Constituency Group.